D-dimer/troponin ratio in the differential diagnosis of acute pulmonary embolism from non-ST elevation myocardial infarction
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to investigate useful cardiac biomarkers in the differential diagnosis of acute pulmonary embolism (APE) with troponin elevation from acute non-ST elevation myocardial infarction (NSTEMI). Methods: A total of 771 consecutive NSTEMI patients with D-dimer measurements and 90 patients with troponin-I (TnI) elevation out of 233 APE patients were enrolled, and cardiac biomarkers were compared. Results: D-dimer elevation was noted in 382 patients with NSTEMI (49.5%), and TnI elevation was noted 90 out of 233 APE patients (38.6%). Unnecessary coronary angiography was performed in 10 patients (11.1%) among 90 APE patients with TnI elevation. D-dimer was significantly elevated in APE than in NSTEMI (9.9 ± 11.6 mg/L vs. 1.8 ± 4.3 mg/L, p < 0.001), whereas TnI was significantly elevated in NSTEMI (22.4 ± 41.5 ng/mL vs. 0.7 ± 1.4 ng/mL, p < 0.001). D-dimer/TnI ratio was significantly higher in APE than in NSTEMI (50.6 ± 85.3 vs. 1.6 ± 5.7, p < 0.001). On receiver operation characteristic curve analysis, the optimal cut-off value for differentiating APE from NSTEMI was 1.12 mg/L for D-dimer (sensitivity 81.1%, specificity 70.2%), 0.72 ng/mL for TnI (sensitivity 80.6%, specificity 78.9%), and 1.82 for D-dimer/TnI ratio (sensitivity 93.3%, specificity 86.6%). Conclusions: D-dimer/TnI ratio would be a simple and useful parameter for differentiating APE with cardiac troponin elevation from NSTEMI. Optimal cardiovascular imaging to identify APE should be considered in patients with D-dimer/ TnI ratio > 1.82 before performing coronary angiography to avoid unnecessary invasive procedure.
Abstract
Background/Aims: The aim of this study was to investigate useful cardiac biomarkers in the differential diagnosis of acute pulmonary embolism (APE) with troponin elevation from acute non-ST elevation myocardial infarction (NSTEMI). Methods: A total of 771 consecutive NSTEMI patients with D-dimer measurements and 90 patients with troponin-I (TnI) elevation out of 233 APE patients were enrolled, and cardiac biomarkers were compared. Results: D-dimer elevation was noted in 382 patients with NSTEMI (49.5%), and TnI elevation was noted 90 out of 233 APE patients (38.6%). Unnecessary coronary angiography was performed in 10 patients (11.1%) among 90 APE patients with TnI elevation. D-dimer was significantly elevated in APE than in NSTEMI (9.9 ± 11.6 mg/L vs. 1.8 ± 4.3 mg/L, p < 0.001), whereas TnI was significantly elevated in NSTEMI (22.4 ± 41.5 ng/mL vs. 0.7 ± 1.4 ng/mL, p < 0.001). D-dimer/TnI ratio was significantly higher in APE than in NSTEMI (50.6 ± 85.3 vs. 1.6 ± 5.7, p < 0.001). On receiver operation characteristic curve analysis, the optimal cut-off value for differentiating APE from NSTEMI was 1.12 mg/L for D-dimer (sensitivity 81.1%, specificity 70.2%), 0.72 ng/mL for TnI (sensitivity 80.6%, specificity 78.9%), and 1.82 for D-dimer/TnI ratio (sensitivity 93.3%, specificity 86.6%). Conclusions: D-dimer/TnI ratio would be a simple and useful parameter for differentiating APE with cardiac troponin elevation from NSTEMI. Optimal cardiovascular imaging to identify APE should be considered in patients with D-dimer/ TnI ratio > 1.82 before performing coronary angiography to avoid unnecessary invasive procedure.
참고문헌 (21)
- Duru S, "Clinical update on pulmonary embolism", Arch Med Sci, 10, pp.557~565 (2014)
- Choi HS, "Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism", J Cardiol, 60, pp.508~513 (2012)
- Konstantinides SV, "2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism", Eur Heart J, 35, pp.3033~3069 (2014)
- Skinner JS, "NICE guidance. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin", Heart, 96, pp.974~978 (2010)
- Stokes NR, "Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea", Open Access Emerg Med, 8, pp.35~45 (2016)
- Stein PD, "D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism : a systematic review", Ann Intern Med, 140, pp.589~602 (2004)
- Wells PS, "Excluding pulmonary embolism at the bedside without diagnostic imaging : management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer", Ann Intern Med, 135, pp.98~107 (2001)
- van Belle A, "Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography", JAMA, 295, pp.172~179 (2006)
- Bayes-Genis A, "D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain", Am Heart J, 140, pp.379~384 (2000)
- Chang SS, "Evaluation of the value of rapid D-dimer test in conjunction with cardiac troponin I test for early risk stratification of myocardial infarction", J Thromb Thrombolysis, 30, pp.472~478 (2010)
- Sakamoto K, "D-dimer is helpful for differentiating acute aortic dissection and acute pulmonary embolism from acute myocardial infarction", Hellenic J Cardiol, 52, pp.123~127 (2011)
- Amsterdam EA, "2014 AHA", ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes : executive summary : a report of the American College of Cardiology, Circulation, pp.2014, 130[DOI]
- Roffi M, "2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology(ESC)", Eur Heart J, 37, pp.267~315 (2016)
- Thygesen K, "Third universal definition of myocardial infarction", J Am Coll Cardiol, 60, pp.1581~1598 (2012)
- Kline JA, "Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism", Crit Care Med, 34, pp.2773~2780 (2006)
- Hahne K, "Impact of D-dimers on the differential diagnosis of acute chest pain: current aspects besides the widely known", Clin Med Insights Cardiol, 8(Suppl 2), pp.1~4 (2014)
- Meyer T, "Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction", J Am Coll Cardiol, 36, pp.1632~1636 (2000)
- Kilinc G, "Significance of serum cardiac troponin I levels in pulmonary embolism", J Thorac Dis, 4, pp.588~593 (2012)
- Ray P, "Differential diagnosis of acute dyspnea : the value of B natriuretic peptides in the emergency department", QJM, 101, pp.831~843 (2008)
- Klok FA, "Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism : a systematic review and meta-analysis", Am J Respir Crit Care Med, 178, pp.425~430 (2008)
- Sanchez O, "Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism : a systematic review", Eur Heart J, 29, pp.1569~1577 (2008)